 |
|
|
|
|
 Future Technologies In Biologics Manufacturing -Transform Bioprocess Productivity And Over Come The Challenges Of Speed, Survival And Innovation
Leveraging Single Use Innovation To Overcome Challenges In Speed, Cost And Maintenance Times Whilst Remaining Flexible For Process & Manufacturing Requirements
Achieving Competitive Advantage And Worldwide Regulatory Compliance In Contract Manufacturing
Road Map into Achieving operational excellence through lean manufacturing
Leveraging Technology With Lean Principles To Overcome Challenges In Speed, Cost Resource, Productivity Whist In Line With Global Regulations, Achieve An Competitive Advantage And Manufacturing Supremacy.
Leveraging Innovation To Transform Bioprocess Productivity: Bridging The Gap Between Upstream Productivity & Down Stream Processes To Over Come Cost, Speed, Regulations & Efficiency Across The Whole Production
Taking a holistic, intergrated approach to disposable manufacturing
|
|
|
 |
|
| |
DELEGATES |
 |
|
| |
 President & COO - Celltrion inc Korea
CEO, President - Reliance Life Sciences
Director Industrial Boitechnology - Pierre Fabre
Chief scientific officer V.P R&D - Vivalis
Project leader, Fermentation Group - CSIRO
Co-Director - berkeley University
Group Leader, Project Manager, Global Development - Bayer
Principal - Tunnel consulting
Senior Director of process Development - Maderex
V.P Biologicals - Innogenetics NV
Director Process Development - Amgen
Director Chemical Bioengineering - ETH Zurich Switzerland
Ark Therapeutics, Manager
Eli Lilly & Co, Operations Manager
Genzyme, Manager
GSK Biologicals, Q&A Manager
Lonza, TBA
Merckle Biotech Gmbh, Managing Director
Merck, Operational Excellence Manager
Pfizer, Plant Manager
Genentech, Q&A Manager
BMS, Director Manufacturing & Technology
Xenova Biomanufacturing, Operations Director |
|
|
Read More 
